Thymic stromal lymphopoietin (TSLP)-mediated dermal inflammation aggravates experimental asthma
Open Access
- 22 February 2012
- journal article
- research article
- Published by Elsevier BV in Mucosal Immunology
- Vol. 5 (3), 342-351
- https://doi.org/10.1038/mi.2012.14
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Dibutyl Phthalate-Induced Thymic Stromal Lymphopoietin Is Required for Th2 Contact Hypersensitivity ResponsesThe Journal of Immunology, 2010
- Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13Journal of Allergy and Clinical Immunology, 2009
- Skin-Derived TSLP Triggers Progression from Epidermal-Barrier Defects to AsthmaPLoS Biology, 2009
- Thymic stromal lymphopoietin overproduced by keratinocytes in mouse skin aggravates experimental asthmaProceedings of the National Academy of Sciences of the United States of America, 2009
- Welcome to the neighborhood: epithelial cell‐derived cytokines license innate and adaptive immune responses at mucosal sitesImmunological Reviews, 2008
- IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC–activated Th2 memory cellsThe Journal of Experimental Medicine, 2007
- Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitisProceedings of the National Academy of Sciences of the United States of America, 2006
- The immunogenetics of asthma and eczema: a new focus on the epitheliumNature Reviews Immunology, 2004
- Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLPNature Immunology, 2002
- The prevalence of childhood atopic eczema in a general populationJournal of the American Academy of Dermatology, 1994